Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06159595 · ClinicalTrials.gov registry record · NA

Behavioral and Neuronal Correlates of Human Mood States

A NA study of Major Depressive Disorder and Epilepsy, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT06159595: Recruiting NA study of Major Depressive Disorder and Epilepsy, sponsored by Stanford University.

NCT06159595 is a NA study of Major Depressive Disorder and Epilepsy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 10 participants, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06159595, a NA study of Major Depressive Disorder and Epilepsy, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Optimizing treatments in mental health requires an easy to obtain, continuous, and objective measure of internal mood. Unfortunately, current standard-of-care clinical scales are sparsely sampled, subject to recency bias, underutilized, and are not validated for acute mood monitoring. The recent shift to remote care also requires novel methods to measure internal mood. Recent advances in computer vision have allowed the accurate quantification of observable speech patterns and facial representations. The continuous and objective nature of these audio-facial behavioral outputs also enable the study of their neural correlates. Here, the investigators hypothesize that video-derived audio-facial behaviors have discrete neural representations in the limbic network and can provide a critical set of reliable longitudinal estimates of mood at low cost across home and clinic settings.

Primary Outcome

Quantitative percent change in each audio-facial feature before and after direct electrical stimulation at each site.

Interventions

  • DEVICE Intracranial electrodes

Study Locations (1)

California

  • Stanford University - Stanford

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2023-12-01
Est. Completion 2025-10-30
Phase NA
Stanford University

1,744 total trials

What NCT06159595 shows while recruiting

NCT06159595 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 377-participant average among 282 other Major Depressive Disorder trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Major Depressive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Intracranial electrodes is the first listed.

NCT06159595 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06159595 about?

NCT06159595 is a clinical study titled "Behavioral and Neuronal Correlates of Human Mood States". Optimizing treatments in mental health requires an easy to obtain, continuous, and objective measure of internal mood. Unfortunately, current standard-of-care clinical scales are sparsely sampled, subject to recency bias, underutilized, and are not validated for acute mood monitoring. The recent shi...

What is the current status of trial NCT06159595?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-12-01. Estimated completion is 2025-10-30.

What conditions does trial NCT06159595 study?

This clinical trial studies the following conditions: Major Depressive Disorder, Epilepsy.

What interventions are being tested in trial NCT06159595?

The interventions under investigation include: Intracranial electrodes (DEVICE).

Who is sponsoring clinical trial NCT06159595?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06159595 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Major Depressive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06159595's enrollment target sits among peer trials

10 272nd of 282 higher than 5 of 282 other Major Depressive Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Major Depressive Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06159595, the US trial registry maintained by the National Library of Medicine. NCT06159595 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.